Stock listing

Filana Therapeutics, Inc.

Selected listing: A2PGL8 · LS · EUR · DE

Filana Therapeutics, Inc. (Lang & Schwarz: A2PGL8), Health Technology. Latest release Sep 22, 2026: Filana Therapeutics Announces FDA Lift of Clinical Hold…

A2PGL8:LSEURDEUpdated October 3, 2026

Ticker: Lang & Schwarz: A2PGL8
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

About Filana Therapeutics, Inc.

Filana Therapeutics, Inc. (FLNA) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.

Latest news from Filana Therapeutics, Inc.

Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy

September 22, 2026

Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update

July 29, 2026

Filana Therapeutics Reports Q1 2026 Financial Results and Business Update

May 7, 2026

Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII

May 5, 2026

Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data

April 15, 2026

All Filana Therapeutics, Inc. news →

Research Filana Therapeutics, Inc.

Filana Therapeutics, Inc. company profile

View the public company page for Filana Therapeutics, Inc. on 6ix.

Filana Therapeutics, Inc. news

Read company news and market updates connected to Filana Therapeutics, Inc..

Filana Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Filana Therapeutics, Inc..